In this study, we provide evidence demonstrating that combined delivery of IL-2 immunocomplexes and anti-IL-5 mAb is highly effective at expanding Foxp3+ Treg cells in the absence of eosinophilia and ameliorating DSS-induced colitis in mice. The gene discussed is IL2; the disease is colitis.